Reckitt Benckiser Group (LON:RKT – Get Free Report)‘s stock had its “hold” rating restated by stock analysts at Jefferies Financial Group in a research report issued on Tuesday,London Stock Exchange reports. They presently have a GBX 5,600 price target on the stock. Jefferies Financial Group’s price objective indicates a potential upside of 20.64% from the company’s previous close.
RKT has been the subject of a number of other research reports. Royal Bank Of Canada restated a “neutral” rating and set a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research report on Friday, May 15th. Berenberg Bank lowered their price objective on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research report on Friday, April 24th. Citigroup dropped their price objective on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a report on Thursday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating on the stock in a research report on Tuesday, April 28th. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of GBX 6,204.29.
View Our Latest Analysis on RKT
Reckitt Benckiser Group Trading Up 0.7%
Insider Activity
In related news, insider Kris Licht sold 5,435 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of GBX 4,753, for a total value of £258,325.55. Also, insider Marybeth Hays acquired 340 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was acquired at an average price of GBX 4,585 per share, with a total value of £15,589. Insiders own 0.45% of the company’s stock.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Goldman’s S&P 500 Target Looks More Reachable After the Latest Rally
- 3 Stocks Diluting Shareholders to Fund Big Long-Term Opportunities
- Father’s Day Investing: 3 Stocks Built for Long-Term Returns
- This Golden Cross Could Send Urban Outfitters to New Highs
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
